$18.5 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$70.75 - $159.54The lowest and highst price in the last 52 weeks.
-23.94xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$0.00 (0.0%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$18.5 Billion|
|Enterprise Value||$18.3 Billion|
|Dividend Yield||$0.00 (0.0%)|
|1 Year Return||+38.7%|
|Outstanding Shares||172 Million|
|Avg 30 Day Volume||1.23 Million|
|Earnings per Share||-$4.95|
|Price to Sales Ratio||14.93|
|Price to Book Ratio||6.53|
|Revenue to Enterprise Value||13.85|
|EBIT to Enterprise Value||-69.59|
|Total Debt to Enterprise Value||0.09|
|Debt to Equity||0.57|
|Gross Profit||$997 Million|
|Net Income||-$334 Million|
|Quarterly Earnings Growth (YoY)||+443.5%|
|Return on Equity||-11.82%|
|Return on Assets||-6.78%|
|Return on Invested Capital||-6.04%|
Exact Sciences swung to a large fourth quarter loss due in part to its purchase of Base Genomics.The Street, 3 months ago
MADISON, Wis., Feb. 16, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $466.3 million for the fourth quarter ended Dec. 31, 2020 and ...PR Newswire, 3 months ago
Leerink Partners Stick to Their Buy Rating for Exact Sciences Corp.Investing.com, 4 months ago